Skip to main content

Advertisement

Log in

Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD)

  • Published:
Applied Research in Quality of Life Aims and scope Submit manuscript

Abstract

Objective

To explore the association between quality of life (QoL) and clinical measures in patients with adult Attention Deficit Hyperactivity Disorder (ADHD); as well as assess the work impairment related to the disease.

Method

A cross-sectional study was conducted in an outpatient clinic of a university hospital in Hungary between 2011–2013 (n = 75). QoL was measured by the European Quality of Life-5 Dimensions questionnaire (EQ-5D). Associations between EQ-5D and clinical measures such as physician’s assessment on a visual analogue scale (physician-VAS), Clinical Global Impression-Severity scale (CGI-S), and Conners’ Adult ADHD Rating Scale (CAARS) subscores were assessed by Spearman-correlation and linear regression models. Productivity loss was estimated using the Work Productivity and Activity Impairment Questionnaire (WPAI) questionnaire.

Results

The mean EQ-5D index and EQ VAS scores were 0.74(SD = 0.22) and 69.5(SD = 19.4), significantly lower than the scores of the age-matched general population. Significant correlations were found between EQ-5D index and clinical measures. No correlation was found between CAARS and physician-VAS, CGI-S. The regression models explained 44.0 % of the EQ-5D index variance. The productivity loss was estimated to 47.5 %.

Conclusion

To our knowledge, this study is the first to analyze the relationship between EQ-5D and clinical measures in adult ADHD in real world practice. Significant correlation between EQ-5D and the clinical measures suggests that EQ-5D is a sensitive measure of the health impairment related to ADHD and psychiatric co-morbidities, thus it contributes to a better understanding of the burden of adult ADHD. The lack of association between the CAARS and physicians’ measures requires further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Notes

  1. See: www.euroqol.org

References

  • Able, S. L., Haynes, V., & Hong, J. (2014). Diagnosis, treatment, and burden of illness among adults with attention-deficit/ hyperactivity disorder in Europe. Pragmatic and Observational Research, 5, 21–33.

    Article  Google Scholar 

  • Addington-Hall, J., & Karla, L. (2001). Measuring quality of life: who should measure quality of life? BMJ, 322(7299), 1417–1420.

    Article  Google Scholar 

  • Agarwal, R., Goldenberg, M., Perry, R., & Ishak, W. W. (2012). The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innovation and Clinical Neuroscience, 9(5–6), 10–21.

    Google Scholar 

  • American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders 5th ed. Washington, DC, USA; 2013.

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. 4th ed., text rev.. Washington, DC, USA; 2000.

  • Bitter, I., Simon, V., Bálint, S., Mészáros, A., & Czobor, P. (2010). How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample. European Archives of Psychiatry and Clinical Neuroscience, 260(4), 287–296.

    Article  Google Scholar 

  • Brod, M., Pohlman, B., Lasser, R., & Hodgkins, P. (2012). Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health and Quality of Life Outcomes, 10, 47. doi:10.1186/1477-7525-10-47.

    Article  Google Scholar 

  • Conners, C. K., Erhardt, D., & Sparrow, E. (1999). Conners’ adult ADHD rating scales (CAARS. North Tonawanda, NY: Multi-Health Systems Inc.

    Google Scholar 

  • Danckaerts, M., Sonuga-Barke, E. J., Banaschewski, T., Buitelaar, J., Döpfner, M., Hollis, C., et al. (2010). The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. European Child & Adolescent Psychiatry, 19(2), 83–105.

    Article  Google Scholar 

  • Faraone, S. V., & Biederman, J. (2005). What is the prevalence of adult ADHD? Results of a population screen of 966 adults. Journal of Attention Disorders, 9(2), 384–91.

    Article  Google Scholar 

  • Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., et al. (2007). Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. The British Journal of Psychiatry, 190, 402–409.

    Article  Google Scholar 

  • Gathje, R. A., Lewandowski, L. J., & Gordon, M. (2008). The role of impairment in the diagnosis of ADHD. Journal of Attention Disorders, 11, 529–537.

    Google Scholar 

  • Guy, W. (2009). Clinical global impressions scale. Modified From: Rush J, et al.: Psychiatric Measures, APA:Washington DC; 2009.

  • Herédi, E., Rencz, F., Balogh, O., Gulácsi, L., Herszényi, K., Holló, P., et al. (2014). Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. The European Journal of Health Economics, 15(Suppl 1), S111–9. doi:10.1007/s10198-014-0600-x.

    Article  Google Scholar 

  • IBM Corp. (2011). IBM SPSS statistics for windows, version 20.0.. Armonk, NY: IBM Corp.

    Google Scholar 

  • Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of Life Research, 22(7), 1717–27. doi:10.1007/s11136-012-0322-4.

    Article  Google Scholar 

  • Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2013). Quality of life in adults aged 50+ with ADHD. Journal of Attention Disorders, 19(5), 405–13.

    Article  Google Scholar 

  • Mandel, M. D., Bálint, A., Lovász, B. D., Gulácsi, L., Strabák, B., Golovics, P. A., et al. (2014). Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. The European Journal of Health Economics, 15(Suppl 1), S121–8. doi:10.1007/s10198-014-0603-7.

    Google Scholar 

  • Matza, L. S., Paramore, C., & Prasad, M. (2005). A review of the economic burden of ADHD. Cost Eff Resour Alloc, 3, 5.

    Article  Google Scholar 

  • Matza, L. S., Devine, M. K., Haynes, V. S., Davies, E. W., Kostelec, J. M., Televantou, F., et al. (2014). Health state utilities associated with adult attention-deficit/hyperactivity disorder. Patient Prefer Adherence, 8, 997–1006.

    Article  Google Scholar 

  • Péntek, M., Harangozó, J., Egerházi, A., Kelemen, O., Gulácsi, L., Baji, P., et al. (2012). Health related quality of life and disease burden of patients with in Hungary. Psychiatria Hungarica, 27(1), 4–17.

    Google Scholar 

  • Péntek, M., Bereczki, D., Gulácsi, L., Mikudina, B., Arányi, Z., Juhos, V., et al. (2013). Survey of adults living with epilepsy in Hungary: health-related quality of life and costs. Ideggyógyászati Szemle, 66(7–8), 251–61.

    Google Scholar 

  • Philipsen, A., Graf, E., Tebartz van Elst, L., Jans, T., Warnke, A., Hesslinger, B., et al. (2010). Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. J Atten Defic Hyperact Disord, 2(4), 203–12. doi:10.1007/s12402-010-0046-7.

    Article  Google Scholar 

  • Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics, 4(5), 353–365.

    Article  Google Scholar 

  • Rothwell, P. M., McDowell, Z., Wong, C. K., & Dorman, P. J. (1997). Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ, 314(7094), 1580–1583.

    Article  Google Scholar 

  • Simon, V., Czobor, P., Balint, S., Meszaros, A., & Bitter, I. (2009). The prevalence and correlates of adult attention deficit hyperactivity disorder (ADHD)—a meta-analysis. The British Journal of Psychiatry, 194, 204–211.

    Article  Google Scholar 

  • Sobanski, E. (2006). Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci., 256 Suppl 1, i26-31. Review. Erratum in. European Archives of Psychiatry and Clinical Neuroscience, 258(3), 192–193.

    Google Scholar 

  • Szende, A., & Németh, R. (2003). Health-related quality of life of the Hungarian population. Orvosi Hetilap, 144(34), 1667–74.

    Google Scholar 

  • Szende, A., Janssen, B., Cabases, J. (2014). Self-reported population health: an international perspective based on EQ-5D. Springer Open.

  • The EuroQol Group. (1990). EuroQol--a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.

    Article  Google Scholar 

  • Upadhyaya, H., Adler, L. A., Casas, M., Kutzelnigg, A., Williams, D., Tanaka, Y., et al. (2013). Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine. Child Adolescent Psychiatry and Mental Health, 7(1), 14. doi:10.1186/1753-2000-7-14.

    Article  Google Scholar 

  • van Emmerik-van Oortmerssen, K., Vedel, E., Koeter, M. W., de Bruijn, K., Dekker, J. J., van den Brink, W., et al. (2013). Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry, 13, 132. doi:10.1186/1471-244X-13-132.

    Article  Google Scholar 

  • van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15(5), 708–15. doi:10.1016/j.jval.2012.02.008.

    Article  Google Scholar 

Download references

Aknowledgments

The authors are thankful to Lívia Balogh, Dóra Kovács, Anna Angyalosi who participated in the data collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Márta Péntek.

Ethics declarations

Disclosure of Potential Conflicts of Interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pulay, A.J., Bitter, I., Papp, S. et al. Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD). Applied Research Quality Life 12, 409–424 (2017). https://doi.org/10.1007/s11482-016-9467-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11482-016-9467-6

Keywords

Navigation